Trial intelligence / Profile preview

Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

NCT05160532Phase 2Completed

Sponsor
Mayo Clinic
Start
Apr 2022
Primary completion
May 2025
Countries
1
01

Overview

Phase 2, randomised trial of dextrose in knee osteoarthritis (OA) (4 arms), sponsored by Mayo Clinic. Started Apr 2022; status: completed.

02

Drugs

dextrose
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT05160532.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05160532.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call